PDT Partners’s Dyne Therapeutics DYN Stock Holding History

PDT Partners’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.32M	Hold	182,986	–	–	0.2%	170
2025 Q4	$3.58M	Sell	182,986 -18,254	-9%	-$346K	0.23%	161
2025 Q3	$2.55M	Sell	201,240 -184,008	-48%	-$2.1M	0.16%	219
2025 Q2	$3.67M	Buy	385,248 +161,072	+72%	+$1.77M	0.21%	169
2025 Q1	$2.34M	Buy	+224,176	New	+$3.21M	0.17%	211
2022 Q4	–	Sell	-19,705	Closed	-$250K	–	705
2022 Q3	$250K	Sell	19,705 -2,918	-13%	-$33.5K	0.04%	651
2022 Q2	$155K	Sell	22,623 -4,612	-17%	-$31.8K	0.01%	852
2022 Q1	$263K	Sell	27,235 -1,549	-5%	-$13.2K	0.02%	749
2021 Q4	$342K	Buy	28,784 +15,275	+113%	+$215K	0.03%	639
2021 Q3	$219K	Buy	+13,509	New	+$240K	0.02%	670

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

PDT Partners's DYN Position: Q1 2026 in Review

PDT Partners held its Dyne Therapeutics (DYN) position steady in Q1 2026 at 182,986 shares worth $3.32M. The position accounts for 0.2% of the portfolio, ranked #170.

PDT Partners first reported a position in DYN in Q3 2021 and has held it in 10 quarters since. The position peaked at $3.67M in Q2 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

PDT Partners held 182,986 shares of Dyne Therapeutics worth $3.32M as of Q1 2026.
PDT Partners left its Dyne Therapeutics share count unchanged in Q1 2026.
Dyne Therapeutics made up 0.2% of PDT Partners's portfolio in Q1 2026, its #170 holding.
PDT Partners first reported a position in Dyne Therapeutics in Q3 2021 and has held it in 10 quarters since.
PDT Partners's Dyne Therapeutics position peaked at $3.67M in Q2 2025.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.